Dr. David Marin
Claim this profileM D Anderson Cancer Center
Studies Blood Cancers
Studies Acute Myeloid Leukemia
5 reported clinical trials
7 drugs studied
Affiliated Hospitals
Clinical Trials David Marin is currently running
Donor T Cell Therapy
for Adenovirus Infections
This phase I trial studies the side effects of allogeneic adenovirus-specific cytotoxic T lymphocytes (donor T cell therapy) and to see how well they work in treating patients with a weakened immune system (immunocompromised) and adenovirus-related disease. Allogeneic adenovirus-specific cytotoxic T lymphocytes are made from donated blood cells grown in the laboratory and are designed to kill viruses that can cause infections in immunocompromised patients with adenovirus-related disease.
Recruiting1 award Phase 1
NK Cells + Chemotherapy
for Blood Cancers
The goal of this clinical research study is to learn about the safety of giving immune cells called natural killer (NK) cells with chemotherapy to patients with leukemia, lymphoma, or multiple myeloma. Immune system cells (such as NK cells) are made by the body to attack foreign or cancerous cells. Researchers think that NK cells you receive from a donor may react against cancer cells in your body, which may help to control the disease.
Recruiting1 award Phase 1 & 29 criteria
More about David Marin
Clinical Trial Related4 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments David Marin has experience with
- Donor T Cell Therapy
- CAR.70/IL15-transduced CB-NK Cells
- Cyclophosphamide
- Fludarabine Phosphate
- SARS-CoV-2 Antigen-specific Cytotoxic T-lymphocytes
- GDX012
Breakdown of trials David Marin has run
Blood Cancers
Acute Myeloid Leukemia
Viral Infections
Immunocompromised
Myelodysplastic Syndrome
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does David Marin specialize in?
David Marin focuses on Blood Cancers and Acute Myeloid Leukemia. In particular, much of their work with Blood Cancers has involved treating patients, or patients who are undergoing treatment.
Is David Marin currently recruiting for clinical trials?
Yes, David Marin is currently recruiting for 2 clinical trials in Houston Texas. If you're interested in participating, you should apply.
Are there any treatments that David Marin has studied deeply?
Yes, David Marin has studied treatments such as Donor T Cell Therapy, CAR.70/IL15-transduced CB-NK cells, Cyclophosphamide.
What is the best way to schedule an appointment with David Marin?
Apply for one of the trials that David Marin is conducting.
What is the office address of David Marin?
The office of David Marin is located at: M D Anderson Cancer Center, Houston, Texas 77030 United States. This is the address for their practice at the M D Anderson Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.